BSX vs. MOH: Boston Scientific vs. Molina Healthcare Stock Comparison

Company Profile

Boston Scientific (BSX) and Molina Healthcare (MOH) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while MOH is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Boston Scientific (BSX) is heavily traded at around 19.73M shares per day, whereas Molina Healthcare (MOH) sees a more moderate 742.07K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Molina Healthcare (MOH) reports a negative ROE of -1.15%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Boston Scientific (BSX) reports 14.12%, ranking against industry peers normally.

Molina Healthcare (MOH) reports a negative net margin of -0.11%, usually indicating a net loss over the period. Meanwhile Boston Scientific (BSX) reports 16.62%, ranking against industry peers normally.

Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Molina Healthcare (MOH) at 1.00%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both Boston Scientific (BSX) at 19.87% and Molina Healthcare (MOH) at 11.75% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Molina Healthcare (MOH) at -56.32% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Molina Healthcare (MOH) at 1.69 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.

Boston Scientific (BSX) at 0.46 carries an industry-typical debt-to-equity mix, while Molina Healthcare (MOH) at 0.95 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Neither Boston Scientific (BSX) nor Molina Healthcare (MOH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Boston Scientific (BSX) nor Molina Healthcare (MOH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Boston Scientific (BSX) trades at 18.04 times trailing earnings, ranked against its peers, while Molina Healthcare (MOH) has no P/E ratio this period.

Molina Healthcare (MOH) at 0.26 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — MOH costs less per dollar of sales, though read it alongside growth and margins.

On P/B ratio, both Boston Scientific (BSX) at 2.42 and Molina Healthcare (MOH) at 2.62 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics